eXp Realty Officially Launches the Co-Sponsor Program, Ushering in New Era of Collaboration and Agent Growth
Notified -
Globe Newswire1-05-2025, 23:00
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition 9-11-2024, 02:51
